Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicoletta Luxi

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2025
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBaseMassimo Carollo, Nicoletta Luxi, Salvatore Crisafulli
Current Opinion in Allergy and Clinical Immunology|August 9, 2023
Anaphylaxis due to antiallergic and antiasthmatic biologicsFabiana Furci, Nicoletta Luxi, Gianenrico Senna, et al.
International Journal of Molecular Sciences|June 2, 2021
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic InertiaGuido Gembillo, Ylenia Ingrasciotta, Salvatore Crisafulli, et al.
Expert Review of Vaccines|September 17, 2020
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerationsJanet Sultana, Giampiero Mazzaglia, Nicoletta Luxi, et al.
BMC Family Practice|October 20, 2021
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trialsSalvatore Crisafulli, Nicoletta Luxi, Raffaele Coppini, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 15, 2024
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance DatabasePaola Maria Cutroneo, Elena Arzenton, Fabiana Furci, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 6, 2023
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and ItalyFrancesco Ciccimarra, Nicoletta Luxi, Chiara Bellitto, et al.
Aging Clinical and Experimental Research|April 7, 2025
Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase<sup>®</sup>Giada Crescioli, Niccolò Lombardi, Elena Arzenton, et al.
Drug Safety|February 15, 2023
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting SystemSalvatore Crisafulli, Paola Maria Cutroneo, Nicoletta Luxi, et al.
European Journal of Endocrinology|June 1, 2021
Global epidemiology of acromegaly: a systematic review and meta-analysisSalvatore Crisafulli, Nicoletta Luxi, Janet Sultana, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2025
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBaseMassimo Carollo, Nicoletta Luxi, Salvatore Crisafulli
Current Opinion in Allergy and Clinical Immunology|August 9, 2023
Anaphylaxis due to antiallergic and antiasthmatic biologicsFabiana Furci, Nicoletta Luxi, Gianenrico Senna, et al.
International Journal of Molecular Sciences|June 2, 2021
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic InertiaGuido Gembillo, Ylenia Ingrasciotta, Salvatore Crisafulli, et al.
Expert Review of Vaccines|September 17, 2020
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerationsJanet Sultana, Giampiero Mazzaglia, Nicoletta Luxi, et al.
BMC Family Practice|October 20, 2021
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trialsSalvatore Crisafulli, Nicoletta Luxi, Raffaele Coppini, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 15, 2024
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance DatabasePaola Maria Cutroneo, Elena Arzenton, Fabiana Furci, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 6, 2023
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and ItalyFrancesco Ciccimarra, Nicoletta Luxi, Chiara Bellitto, et al.
Aging Clinical and Experimental Research|April 7, 2025
Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase<sup>®</sup>Giada Crescioli, Niccolò Lombardi, Elena Arzenton, et al.
Drug Safety|February 15, 2023
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting SystemSalvatore Crisafulli, Paola Maria Cutroneo, Nicoletta Luxi, et al.
European Journal of Endocrinology|June 1, 2021
Global epidemiology of acromegaly: a systematic review and meta-analysisSalvatore Crisafulli, Nicoletta Luxi, Janet Sultana, et al.
Pageof 3